Vericel Corporation (VCEL) Earnings Call Analysis

NASDAQ · Healthcare · Biotechnology

22/25

Growth 5 Margin 4 Expansion 5 Platform 4 Financial 4

latest quarter score

Earnings Reports

22
Vericel (VCEL) Q2 2026: Macy Drives 23% Growth as $200M Buyback Signals Confident Cash Trajectory
July 30, 2026
24
Vericel (VCEL) Q1 2026: Burn Care Jumps 90%, Macy Sales Force Drives Sustained Growth
May 07, 2026
19
Vericel (VCEL) Q4 2025: Macy Franchise Grows 23% as Expanded Sales Force and Arthro Adoption Accelerate Penetration
February 26, 2026
19
Vericel (VCEL) Q3 2025: Macy Revenue Jumps 25% as Arthro Drives Implant Surge
November 06, 2025
19
Vericel (VCEL) Q2 2025: Macy Arthro Drives 40% Growth in Key Segment, Salesforce Expansion Accelerates
July 31, 2025
21
Vericel (VCEL) Q1 2025: Macy-Arthro Surgeons Drive 30%+ Biopsy Growth, Setting Up Back-Half Acceleration
July 07, 2025

Browse all companies